Business
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
OSAKA, Japan & CAMBRIDGE, Mass., September 16, 2025--Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s first-of-its-kind sailing cargo trimaran. VELA designed and will operate a fleet of new generation sailing cargo vessels, powered 100 percent by wind when at sea. Purpose-built to handle pharmaceutical products, VELA will offer
About this update from Takeda Pharmaceutical Co. Ltd.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/e80b7c8290f5787cbfa4de7c7a900bda"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YB6gNZVk1BXGWuZsWp0zmw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e80b7c8290f5787cbfa4de7c7a900bda","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Xf37jjxj7HCfy96dGCanhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/e80b7c8290f5787cbfa4de7c7a900bda","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"VELA to operate the world’s first sailing cargo trimaran powered by 100 percent wind when at sea1 to sail between Europe and the U.S.","length":133,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Takeda to become the first biopharmaceutical company to ship its products on VELA’s wind-powered trimaran, starting a new era of sustainable shipping in pharma","length":159,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":292,"olType":false},{"type":"text","content":"OSAKA, Japan & CAMBRIDGE, Mass., September 16, 2025--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s first-of-its-kind sailing cargo trimaran. VELA designed and will operate a fleet of new generation sailing cargo vessels, powered 100 percent by wind when at sea. Purpose-built to handle pharmaceutical products, VELA will offer reliable, secure and ultra-low-emission sea freight shipping. The maiden voyage is planned for late 2026.","length":626,"tagName":"p"},{"type":"text","content":"VELA’s new wind-powered sea freight will offer a climate-conscious alternative to other transportation for the pharmaceutical industry – cutting use-related greenhouse gas emissions by up to 99 percent compared to air freight and up to 90 percent compared to container ships.2 The remaining emissions primarily come from the minimal engine use for maneuvering into harbors. The trimaran will be equipped w...